Marek Mirowski Selected Research

Marek Mirowski Research Topics

Disease

21	Neoplasms (Cancer) 03/2023 - 02/2002
6	Breast Neoplasms (Breast Cancer) 03/2023 - 01/2003
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2013 - 09/2006
3	Peptic Ulcer (Peptic Ulcers) 04/2019 - 11/2014
3	Inflammation (Inflammations) 03/2016 - 01/2011
3	Infections 03/2016 - 09/2002
3	Adenocarcinoma 01/2005 - 01/2003
2	Lung Neoplasms (Lung Cancer) 06/2022 - 10/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 10/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 10/2006
2	Melanoma (Melanoma, Malignant) 01/2017 - 01/2015
2	Acute Promyelocytic Leukemia 05/2005 - 03/2003
1	Carcinogenesis 06/2022
1	Leukemia 01/2020
1	Multiple Myeloma 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Major Depressive Disorder (Major Depressive Disorders) 01/2019
1	Disease Progression 01/2013
1	Colorectal Neoplasms (Colorectal Cancer) 08/2009
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2005
1	Neoplasm Metastasis (Metastasis) 01/2005
1	Thyroid Neoplasms (Thyroid Cancer) 01/2005

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2005
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2009 - 11/2005
3	Metalloproteases (Metalloproteinases)IBA 02/2022 - 04/2019
3	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 01/2005
3	Messenger RNA (mRNA)IBA 10/2020 - 08/2016
3	Adenosine Triphosphate (ATP)IBA 10/2020 - 01/2018
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2017 - 06/2013
3	UreaseIBA 03/2016 - 01/2012
3	morphiceptinIBA 01/2005 - 12/2002
2	RNA (Ribonucleic Acid)IBA 10/2020 - 01/2005
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2020 - 01/2019
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 03/2003
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 09/2006
2	CarcinogensIBA 01/2019 - 01/2018
2	XenobioticsIBA 01/2019 - 10/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2016 - 11/2014
2	FibrinIBA 06/2014 - 06/2013
2	Cladribine FDA LinkGeneric 09/2012 - 01/2012
2	Amifostine (Ethyol)FDA LinkGeneric 05/2005 - 03/2003
2	Caspase 3 (Caspase-3)IBA 05/2005 - 03/2003
2	endomorphin 2IBA 02/2005 - 01/2005
2	Opioid Receptors (Opioid Receptor)IBA 02/2005 - 01/2005
2	IodineIBA 01/2005 - 01/2003
2	Peptides (Polypeptides)IBA 01/2005 - 01/2005
1	Therapeutic UsesIBA 03/2023
1	Organophosphonates (Phosphonates)IBA 03/2023
1	ElementsIBA 06/2022
1	Membrane-Associated Matrix MetalloproteinasesIBA 02/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 04/2019
1	Cytochrome P-450 CYP2C19IBA 04/2019
1	Cytochrome P-450 CYP3AIBA 01/2019
1	hydrazine (hydrazine dihydrochloride)IBA 01/2017
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2017
1	Arsenic Trioxide (Trisenox)FDA Link 01/2015
1	PolymersIBA 06/2014
1	Fibrinogen (Factor I)FDA Link 06/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2014
1	ChromonesIBA 06/2013
1	Complementary DNA (cDNA)IBA 01/2013
1	Protein Isoforms (Isoforms)IBA 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2012
1	Rituximab (Mabthera)FDA Link 09/2012
1	fludarabineIBA 01/2012
1	Blood Group Antigens (Blood Groups)IBA 08/2009
1	Leucovorin (Folinic Acid)FDA Link 08/2009
1	Fluorouracil (Carac)FDA LinkGeneric 08/2009
1	multidrug resistance-associated protein 1IBA 02/2007
1	Membrane Transport Proteins (Biological Pump)IBA 11/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2005
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2005
1	Etoposide (VP 16)FDA LinkGeneric 05/2005
1	AntibodiesIBA 01/2005
1	HMGA ProteinsIBA 01/2005
1	LigandsIBA 01/2005
1	sodium-iodide symporter (sodium iodide symporter)IBA 01/2005
1	endomorphin 1IBA 01/2005
1	Opioid Peptides (Opioid Peptide)IBA 08/2004
1	mu Opioid Receptors (mu Opioid Receptor)IBA 08/2004
1	Trastuzumab (Herceptin)FDA Link 01/2003
1	Monoclonal AntibodiesIBA 01/2003
1	PlatinumIBA 02/2002
1	Cisplatin (Platino)FDA LinkGeneric 02/2002

Therapy/Procedure

8	Therapeutics 10/2020 - 09/2002
5	Drug Therapy (Chemotherapy) 09/2018 - 02/2002
2	Radiotherapy 01/2005 - 02/2002
1	Intraperitoneal Injections 02/2002